{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:39:51Z","timestamp":1790836791935,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T00:00:00Z","timestamp":1389052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-7","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T10:03:31Z","timestamp":1389089011000},"source":"Crossref","is-referenced-by-count":101,"title":["Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986\u201390) and in the nationwide immunisation program"],"prefix":"10.1186","volume":"14","author":[{"given":"Thomas J","family":"Peto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maimuma E","family":"Mendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamundow","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilton C","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"2983_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2893.2003.00453.x-i1","volume":"14","author":"CL Lai","year":"2007","unstructured":"Lai CL, Yuen MF: The natural history of chronic hepatitis B. J Viral Hepatitis. 2007, 14: 6-10.","journal-title":"J Viral Hepatitis"},{"issue":"9663","key":"2983_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Chu CM: Hepatitis B virus infection. Lancet. 2009, 373 (9663): 582-592. 10.1016\/S0140-6736(09)60207-5.","journal-title":"Lancet"},{"issue":"2\u20133","key":"2983_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1383-5742(00)00027-2","volume":"462","author":"CP Wild","year":"2000","unstructured":"Wild CP, Hall AJ: Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res. 2000, 462 (2\u20133): 381-393.","journal-title":"Mutat Res"},{"issue":"2","key":"2983_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ijc.26333","volume":"130","author":"BS Sylla","year":"2012","unstructured":"Sylla BS, Wild CP: A million Africans a year dying from cancer by 2030: What can cancer research and control offer to the continent?. Int J Cancer. 2012, 130 (2): 245-250. 10.1002\/ijc.26333.","journal-title":"Int J Cancer"},{"key":"2983_CR5","first-page":"93","volume-title":"A review of human carcinogens. Part B: Biological agents. IARC monographs on the evaluation of carcinogenic risks to humans Volume 100B","author":"International Agency for Research on Cancer","year":"2012","unstructured":"International Agency for Research on Cancer: Hepatitis B Virus. A review of human carcinogens. Part B: Biological agents. IARC monographs on the evaluation of carcinogenic risks to humans Volume 100B. 2012, Lyon, France: IARC, 93-133."},{"issue":"40","key":"2983_CR6","first-page":"405","volume":"84","author":"World Health Organisation","year":"2009","unstructured":"World Health Organisation: Hepatitis B vaccines: WHO position paper. Weekly Epidemiol Record. 2009, 84 (40): 405-419.","journal-title":"Weekly Epidemiol Record"},{"issue":"4","key":"2983_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/infdis\/166.4.764","volume":"166","author":"J Chotard","year":"1992","unstructured":"Chotard J, Inskip HM, Hall AJ, et al: The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis. 1992, 166 (4): 764-768. 10.1093\/infdis\/166.4.764.","journal-title":"J Infect Dis"},{"issue":"8853","key":"2983_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0140-6736(93)93137-P","volume":"341","author":"M Fortuin","year":"1993","unstructured":"Fortuin M, Chotard J, Jack AD, et al: Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet. 1993, 341 (8853): 1129-1131. 10.1016\/0140-6736(93)93137-P.","journal-title":"Lancet"},{"issue":"21","key":"2983_CR9","first-page":"5782","volume":"47","author":"AJ Hall","year":"1987","unstructured":"Hall AJ, Inskip HM, Loik F, et al: for the gambia hepatitis study group. The gambia hepatitis intervention study. Cancer Res. 1987, 47 (21): 5782-5787.","journal-title":"Cancer Res"},{"issue":"8646","key":"2983_CR10","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0140-6736(89)92454-9","volume":"333","author":"AJ Hall","year":"1989","unstructured":"Hall AJ, Inskip HM, Loik F, et al: for the Gambia Hepatitis Study Group. Hepatitis B vaccine in the expanded programme of immunisation: The Gambian experience. Lancet. 1989, 333 (8646): 1057-1060. 10.1016\/S0140-6736(89)92454-9.","journal-title":"Lancet"},{"issue":"11","key":"2983_CR11","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1158\/1055-9965.EPI-08-0303","volume":"17","author":"S Viviani","year":"2008","unstructured":"Viviani S, Carrieri P, Bah E, et al: 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17 (11): 3216-3223. 10.1158\/1055-9965.EPI-08-0303.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"2983_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.vaccine.2006.10.023","volume":"25","author":"MA van der Sande","year":"2007","unstructured":"van der Sande MA, Mendy M, Waight P, et al: Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life. Vaccine. 2007, 25 (8): 1509-1512. 10.1016\/j.vaccine.2006.10.023.","journal-title":"Vaccine"},{"issue":"11","key":"2983_CR13","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1086\/503433","volume":"193","author":"MA van der Sande","year":"2006","unstructured":"van der Sande MA, Waight P, Mendy M, et al: Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis. 2006, 193 (11): 1528-1535. 10.1086\/503433.","journal-title":"J Infect Dis"},{"issue":"8","key":"2983_CR14","doi-asserted-by":"publisher","first-page":"e753","DOI":"10.1371\/journal.pone.0000753","volume":"2","author":"MA van der Sande","year":"2007","unstructured":"van der Sande MA, Waight PA, Mendy M, et al: Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One. 2007, 2 (8): e753-10.1371\/journal.pone.0000753.","journal-title":"PLoS One"},{"issue":"23\u201324","key":"2983_CR15","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1016\/S0264-410X(99)00178-4","volume":"17","author":"S Viviani","year":"1999","unstructured":"Viviani S, Jack A, Hall AJ, et al: Hepatitis B vaccination in infancy in the gambia: protection against carriage at 9 years of age. Vaccine. 1999, 17 (23\u201324): 2946-2950.","journal-title":"Vaccine"},{"issue":"7364","key":"2983_CR16","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/bmj.325.7364.569","volume":"325","author":"H Whittle","year":"2002","unstructured":"Whittle H, Jaffar S, Wansbrough M, et al: Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ. 2002, 325 (7364): 569-573. 10.1136\/bmj.325.7364.569.","journal-title":"BMJ"},{"issue":"8744","key":"2983_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/0140-6736(91)91367-4","volume":"337","author":"HC Whittle","year":"1991","unstructured":"Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S: Vaccination against hepatitis B and protection against chronic viral carriage in the gambia. Lancet. 1991, 337 (8744): 747-750. 10.1016\/0140-6736(91)91367-4.","journal-title":"Lancet"},{"issue":"6899","key":"2983_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1136\/bmj.307.6899.276","volume":"307","author":"AJ Hall","year":"1993","unstructured":"Hall AJ: Hepatitis B, vaccination: protection for how long and against what?. BMJ. 1993, 307 (6899): 276-277. 10.1136\/bmj.307.6899.276.","journal-title":"BMJ"},{"issue":"2","key":"2983_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1086\/314578","volume":"179","author":"AD Jack","year":"1999","unstructured":"Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC: What level of hepatitis B antibody is protective?. J Infect Dis. 1999, 179 (2): 489-492. 10.1086\/314578.","journal-title":"J Infect Dis"},{"issue":"11","key":"2983_CR20","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1473-3099(10)70217-6","volume":"10","author":"JJ Wenzel","year":"2010","unstructured":"Wenzel JJ, Jilg W: Loss of antibodies, but not of protection. Lancet Infect Dis. 2010, 10 (11): 738-739. 10.1016\/S1473-3099(10)70217-6.","journal-title":"Lancet Infect Dis"},{"issue":"1337","key":"2983_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1098\/rspb.1993.0102","volume":"253","author":"WJ Edmunds","year":"1993","unstructured":"Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC: The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993, 253 (1337): 197-201. 10.1098\/rspb.1993.0102.","journal-title":"Proc Biol Sci"},{"issue":"49","key":"2983_CR22","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","volume":"26","author":"AR Zanetti","year":"2008","unstructured":"Zanetti AR, Van Damme P, Shouval D: The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008, 26 (49): 6266-6273. 10.1016\/j.vaccine.2008.09.056.","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"2983_CR23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S1590-8658(10)60685-8","volume":"43","author":"L Romano","year":"2011","unstructured":"Romano L, Paladini S, Van Damme P, Zanetti AR: The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis. 2011, 43 (Suppl 1): S2-S7.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"2983_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.vaccine.2009.10.068","volume":"28","author":"J Poorolajal","year":"2010","unstructured":"Poorolajal J, Mahmoodi M, Majdzadeh R, Nasseri-Moghaddam S, Haghdoost A, Fotouhi A: Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010, 28 (3): 623-631. 10.1016\/j.vaccine.2009.10.068.","journal-title":"Vaccine"},{"issue":"7","key":"2983_CR25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1470-2045(08)70175-X","volume":"9","author":"DM Parkin","year":"2008","unstructured":"Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H: Cancer in indigenous Africans. Part I: Burden, distribution, and trends. Lancet Oncol. 2008, 9 (7): 683-692. 10.1016\/S1470-2045(08)70175-X.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2983_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1473-3099(02)00264-5","volume":"2","author":"V Madhava","year":"2002","unstructured":"Madhava V, Burgess C, Drucker E: Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002, 2 (5): 293-302. 10.1016\/S1473-3099(02)00264-5.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"2983_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/09674845.2005.11732692","volume":"62","author":"CI Mboto","year":"2005","unstructured":"Mboto CI, Davies-Russell A, Fielder M, Jewell AP: Hepatitis C antibodies in asymptomatic first-time blood donors in The Gambia: prevalence and risk factors. Br J Biomed Sci. 2005, 62 (2): 89-91.","journal-title":"Br J Biomed Sci"},{"issue":"1","key":"2983_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/hep.20027","volume":"39","author":"GD Kirk","year":"2004","unstructured":"Kirk GD, Lesi OA, Mendy M, et al: The gambia liver cancer study: infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology. 2004, 39 (1): 211-219. 10.1002\/hep.20027.","journal-title":"Hepatology"},{"issue":"2","key":"2983_CR29","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.ijid.2010.09.005","volume":"15","author":"RM Merrill","year":"2011","unstructured":"Merrill RM, Hunter BD: Seroprevalence of markers for hepatitis B viral infection. Int J Infect Dis. 2011, 15 (2): e78-e121. 10.1016\/j.ijid.2010.09.005.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"2983_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/infdis\/161.6.1112","volume":"161","author":"HC Whittle","year":"1990","unstructured":"Whittle HC, Inskip H, Bradley AK, et al: The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis. 1990, 161 (6): 1112-1115. 10.1093\/infdis\/161.6.1112.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:32:33Z","timestamp":1716395553000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2983"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,7]]},"article-number":"7"}}